Australia’s Groundbreaking Stem Cell Sciences Closed By New U.S. Owner
This article was originally published in PharmAsia News
Stem Cell Sciences, Australia's first stem-cell biotech, is going out of business, the result of a decision by its new U.S. owner. StemCells of California acquired the intellectual property of SCS for handling embryonic stem cells and other technology along with patents on 20 sets of products. The closing of SCS leaves Australia with only Mesoblast, since Bresagen ended its stem-cell work and Embryonic Stemcells relocated to Singapore. The California company bought SCS in March for $4 million. (Click here for more
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.